On September 5, 2022, Prestige Biologics Co., Ltd closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,900 KRW | +1.60% |
|
+0.68% | -6.12% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.12% | 75.99M | |
+2.88% | 93.97B | |
+6.58% | 41.61B | |
-13.20% | 33.32B | |
+77.12% | 28.8B | |
-16.02% | 15.61B | |
-8.17% | 13.27B | |
-12.49% | 11.46B | |
+162.44% | 10.06B | |
-54.92% | 9.09B |
- Stock Market
- Equities
- A950210 Stock
- News Prestige BioPharma Limited
- Prestige Biologics Co., Ltd. announced that it has received KRW 6.893915 billion in funding from Prestige BioPharma Limited